Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-05-30
2006-05-30
Shah, Mukund J. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S315000, C514S357000, C546S194000, C546S192000, C546S196000, C546S201000, C546S199000, C546S207000, C546S229000, C548S452000, C548S465000, C548S469000
Reexamination Certificate
active
07053078
ABSTRACT:
Compounds of formula (I)in which R2, X, Y, Cy, L and Lp(D)nhave the meanings given in the specification, are inhibitors of the serine protease, Factor Xa and are useful in the treatment of cardiovascular disorders.
REFERENCES:
patent: 5346907 (1994-09-01), Kerwin et al.
patent: 6545055 (2003-04-01), Zhu et al.
patent: 796866 (1997-09-01), None
patent: WO 91/00725 (1991-01-01), None
patent: WO 97/49404 (1997-12-01), None
patent: WO 98/47876 (1998-10-01), None
patent: WO 99/00121 (1999-01-01), None
patent: WO 99/00126 (1999-01-01), None
patent: WO 99/00127 (1999-01-01), None
patent: WO 99/00128 (1999-01-01), None
patent: 9911657 (1999-03-01), None
patent: 9911658 (1999-03-01), None
patent: 9925686 (1999-05-01), None
patent: WO 00/39092 (2000-07-01), None
patent: WO 00/39111 (2000-07-01), None
patent: WO 00/39117 (2000-07-01), None
patent: WO 00/39118 (2000-07-01), None
patent: WO 00/71493 (2000-11-01), None
patent: WO 00/71507 (2000-11-01), None
patent: WO 00/71508 (2000-11-01), None
patent: WO 00/76970 (2000-12-01), None
patent: WO 00/76971 (2000-12-01), None
patent: WO 00/77027 (2000-12-01), None
Uehara et al,PubMed 12759451, also cited as J.Immunol., 170/11,5690-6(2003).
Humphries et al, PubMed Abstract 10550187, also cited as J. Vasc. Surg. 30/5,894-9(19999).
van Aken et al, PubMed Abstract 10780312, also cited as Thromb. Haemost.,83/4,536-9(2000).
de Jonge et al, PubMed Abstract 961592, also cited as Drugs, 55/6, 767-77(1998).
Jones, Stuart D, et al., Bioorganic & Medicinal Chemistry Letters 11 (2001) 733-736.
Camp Nicholas Paul
Engel David Birenbaum
Jones Stuart Donald
Liebeschuetz John Walter
Masters John Joseph
Eli Lilly and Company
Hay Martin A.
Patel Sudhaker B.
Shah Mukund J.
LandOfFree
Serine protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Serine protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serine protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3530791